An innovative CRO partner to support your novel therapeutic modality
Celerion has comprehensive PK expertise for your NAT program
NATs can exist as a range of structures including siRNA, antisense oligonucleotides, mRNAs, and DNA-based therapeutics. Bioanalytical methods to quantitatively detect NATs are therefore varied, too. At Celerion, we have hands-on expertise in pharmacokinetics across platforms to provide support for your molecule, whether that requires LC/MS, qPCR, or hybridization ELISA.
Celerion’s detailed methods and expert scientists make the difference
Sample handling and extraction procedures for NAT methods are of utmost importance in study design. At Celerion, we have decades of experience tailoring our methods to ensure stability of reagents and analytes while maximizing assay performance, all within a regulated setting.
Visit our resources page to find case studies and scientific presentations showcasing our thoughtful, scientifically driven approaches to assay development across PK, immunogenicity, and biomarker methods.


